Filters: keyword is Purinergic P1 [Clear All Filters]
- 2002
Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release,
Eur J Pharmacol, vol. 454, no. 2-3, pp. 177-82.
- 1999
Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat,
J Pharm Sci, vol. 88, no. 3, pp. 306-12.
- 1997
Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling,
Int J Clin Pharmacol Ther, vol. 35, no. 10, pp. 442-6.
8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo,
J Pharmacol Exp Ther, vol. 283, no. 2, pp. 800-8.
- 1996
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo,
Br J Pharmacol, vol. 118, no. 2, pp. 369-77.
Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats,
Eur J Pharmacol, vol. 308, no. 3, pp. 311-4.
Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo,
J Pharmacol Exp Ther, vol. 279, no. 3, pp. 1439-46.
- 1995
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor,
J Med Chem, vol. 38, no. 20, pp. 4000-6.
8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor,
Eur J Pharmacol, vol. 290, no. 3, pp. 189-99.
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline,
Br J Pharmacol, vol. 115, no. 7, pp. 1253-9.
- 1994
Partial agonism of theophylline-7-riboside on adenosine receptors,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 6, pp. 638-45.
- 1993



